Local and Systemic side effects of COVID-19 Vaccines
-
Published:2023-12-14
Issue:1
Volume:2
Page:37-48
-
ISSN:3005-480X
-
Container-title:International Journal of Clinical Medical Research
-
language:en
-
Short-container-title:IJCMR
Author:
Alatawi Ahmed D.,Elgendy Marwa O.,Sayed Ahmed M.,Shafiq Shafiq Naguib,El-Bahrawy Ali H.,Mallhi Tauqeer Hussain,Khan Yusra Habib,Alzarea Abdulaziz Ibrahim,Alotaibi Nasser Hadal,Alanazi Abdullah Salah
Abstract
<p class="MsoNormal" style="text-align: justify;"><strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">Background:</span></strong></p>
<p class="MsoNormal" style="text-align: justify;"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">To increase the public's acceptance of the vaccine, knowledge of its side effects is crucial. Thus, the purpose of this study was to identify side effects in the Saudi population following vaccinations with Pfizer BioNTech and AstraZeneca.<strong> </strong></span></p>
<p class="MsoNormal" style="text-align: justify;"><strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">Method:</span></strong></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">In Saudi Arabia, an online survey was conducted between March and October of 2021. Participants from Saudi Arabia who received two doses of the Pfizer BioNTech or AstraZeneca vaccine took part. The survey identified side effects following vaccinations. </span></p>
<p class="MsoNormal" style="text-align: justify;"><strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">Results: </span></strong></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">AstraZeneca and Pfizer BioNTech administered vaccines to 174 and 224 of the 398 subjects, respectively. Fatigue (83.9%), local pain (78.2%), bone or joint pain (74.1%), fever (67.8%), vomiting or loss of appetite (24.1%), swelling (24.1%), and redness (21.8%) were the most commonly reported side effects for participants who took AstraZeneca.<span style="mso-spacerun: yes;"> </span></span></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi;">For the participants who received Pfizer BioNTech, the most common adverse effects that were reported were fatigue (43.8%), bone or joint pain (38.4%), swelling (28.6%), fever (22.8%), redness (15.1%), and nausea or vomiting (11.2%). Local pain accounted for 90.6% of the adverse effects that participants reported. </span></p>
<p class="MsoNormal" style="text-align: justify;"><strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi; color: black;">Conclusions:</span></strong></p>
<p class="MsoNormal"><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-hansi-theme-font: minor-bidi; mso-bidi-theme-font: minor-bidi; color: black;">After receiving the COVID-19 vaccine, the majority of participants reported experiencing at least one side effect. Whereas the AstraZeneca vaccination was linked to a higher prevalence of systemic side effects, the Pfizer BioNTech vaccination was linked to a higher prevalence of local adverse effects. Most adverse events following vaccination are not fatal. After receiving an AstraZeneca or Pfizer BioNTech vaccination, side effects were more common in women and younger age groups. Vaccinations against coronavirus have a good safety record.</span></p>
Publisher
Pharaoh Academy International Publishing Co., Limited
Reference74 articles.
1. Gralinski, L.E., A. Bankhead III, S. Jeng, V.D. Menachery, S. Proll, S.E. Belisle, M. Matzke, B.-J.M. Webb-Robertson, M.L. Luna, and A.K. Shukla, Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. MBio, 2013. 4(4): p. e00271-13. 2. Elgendy, M.O. and M.E. Abdelrahim, Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy. Journal of Medical Virology, 2021. 3. Eid, R.A., M.O. Elgendy, A.O. El-Gendy, S.O. Elgendy, L. Belbahri, A.M. Sayed, and M.E. Rateb, Efficacy of ceftazidime and cefepime in the management of COVID-19 patients: single center report from Egypt. Antibiotics, 2021. 10(11): p. 1278. 4. Andrzejczak-Grządko, S., Z. Czudy, and M. Donderska, Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci, 2021. 25(12): p. 4418-4421. 5. Mehboob, R., F. Ahmad, A. Qayyum, M.A. Rana, S.A. Gilani, M.A. Tariq, G. Ali, S.J. Akram, and J. Akram, Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach. medRxiv, 2020.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|